Parkman Healthcare Partners as of June 30, 2021
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 82 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Aclaris Therapeutics (ACRS) | 5.8 | $26M | 1.5M | 17.56 | |
Dex (DXCM) | 4.7 | $22M | 51k | 427.01 | |
Charles River Laboratories (CRL) | 4.2 | $19M | 52k | 369.91 | |
Intuitive Surgical Com New (ISRG) | 3.9 | $18M | 20k | 919.65 | |
United Therapeutics Corporation (UTHR) | 3.7 | $17M | 94k | 179.41 | |
Iqvia Holdings (IQV) | 3.6 | $17M | 68k | 242.32 | |
Danaher Corporation (DHR) | 3.3 | $15M | 56k | 268.36 | |
Humana (HUM) | 3.2 | $15M | 33k | 442.73 | |
Natera (NTRA) | 3.0 | $14M | 121k | 113.53 | |
Alnylam Pharmaceuticals (ALNY) | 2.8 | $13M | 75k | 169.51 | |
Avantor (AVTR) | 2.7 | $13M | 354k | 35.51 | |
Peregrine Pharmaceuticals (CDMO) | 2.7 | $12M | 475k | 25.65 | |
Dicerna Pharmaceuticals | 2.5 | $11M | 305k | 37.32 | |
Insulet Corporation (PODD) | 2.1 | $9.7M | 35k | 274.50 | |
Icad Com New (ICAD) | 2.0 | $9.2M | 531k | 17.31 | |
Itamar Med Sponsored Ads | 1.7 | $8.0M | 338k | 23.55 | |
Repligen Corporation (RGEN) | 1.7 | $7.7M | 39k | 199.61 | |
Acceleron Pharma | 1.6 | $7.5M | 60k | 125.50 | |
Xenon Pharmaceuticals (XENE) | 1.6 | $7.5M | 401k | 18.62 | |
Cooper Cos Com New | 1.6 | $7.4M | 19k | 396.28 | |
Seagen | 1.6 | $7.1M | 45k | 157.87 | |
Dentsply Sirona (XRAY) | 1.5 | $7.0M | 111k | 63.26 | |
Arcus Biosciences Incorporated (RCUS) | 1.5 | $6.8M | 247k | 27.46 | |
Horizon Therapeutics Pub L SHS | 1.5 | $6.8M | 72k | 93.64 | |
Stereotaxis Com New (STXS) | 1.4 | $6.5M | 679k | 9.64 | |
Gossamer Bio (GOSS) | 1.4 | $6.4M | 787k | 8.12 | |
Nevro (NVRO) | 1.3 | $5.9M | 36k | 165.79 | |
Catalent (CTLT) | 1.3 | $5.9M | 55k | 108.11 | |
Protagonist Therapeutics (PTGX) | 1.3 | $5.8M | 130k | 44.88 | |
Apollo Endosurgery | 1.2 | $5.6M | 691k | 8.10 | |
BioCryst Pharmaceuticals (BCRX) | 1.2 | $5.6M | 352k | 15.81 | |
Ionis Pharmaceuticals (IONS) | 1.2 | $5.4M | 136k | 39.89 | |
InfuSystem Holdings (INFU) | 1.1 | $5.2M | 252k | 20.79 | |
Axogen (AXGN) | 1.1 | $5.1M | 238k | 21.61 | |
Immunic (IMUX) | 1.1 | $5.1M | 414k | 12.26 | |
IDEXX Laboratories (IDXX) | 1.1 | $4.8M | 7.7k | 631.54 | |
Codexis (CDXS) | 1.0 | $4.7M | 206k | 22.66 | |
Seaspine Holdings | 1.0 | $4.6M | 225k | 20.51 | |
Mannkind Corp Com New (MNKD) | 1.0 | $4.4M | 805k | 5.45 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.8 | $3.8M | 90k | 41.73 | |
Madrigal Pharmaceuticals (MDGL) | 0.8 | $3.5M | 36k | 97.41 | |
Bridgebio Pharma (BBIO) | 0.8 | $3.5M | 58k | 60.95 | |
Outset Med (OM) | 0.8 | $3.5M | 70k | 49.97 | |
Kodiak Sciences (KOD) | 0.7 | $3.4M | 37k | 92.99 | |
Harvard Bioscience (HBIO) | 0.7 | $3.4M | 402k | 8.33 | |
Supernus Pharmaceuticals (SUPN) | 0.7 | $3.1M | 100k | 30.79 | |
Inotiv (NOTV) | 0.7 | $3.1M | 115k | 26.68 | |
Sutro Biopharma (STRO) | 0.7 | $3.0M | 163k | 18.59 | |
Health Catalyst (HCAT) | 0.6 | $2.8M | 51k | 55.51 | |
89bio (ETNB) | 0.6 | $2.5M | 136k | 18.70 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.5 | $2.5M | 347k | 7.09 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.5 | $2.5M | 81k | 30.36 | |
Sientra | 0.5 | $2.4M | 302k | 7.96 | |
Schrodinger (SDGR) | 0.5 | $2.3M | 31k | 75.60 | |
Biolinerx Sponsored Ads (BLRX) | 0.5 | $2.1M | 734k | 2.81 | |
Trillium Therapeutics Com New | 0.4 | $2.0M | 211k | 9.70 | |
Oncternal Therapeutics | 0.4 | $2.0M | 415k | 4.75 | |
Altimmune Com New (ALT) | 0.4 | $2.0M | 200k | 9.85 | |
Kadmon Hldgs | 0.4 | $1.9M | 502k | 3.87 | |
Biosante Pharmaceuticals (ANIP) | 0.4 | $1.9M | 55k | 35.05 | |
Performant Finl (PFMT) | 0.4 | $1.9M | 497k | 3.75 | |
Castlight Health CL B | 0.4 | $1.8M | 678k | 2.63 | |
Recro Pharma (SCTL) | 0.4 | $1.8M | 771k | 2.31 | |
Catalyst Biosciences Com New | 0.4 | $1.7M | 393k | 4.33 | |
Surface Oncology | 0.4 | $1.7M | 228k | 7.46 | |
Tela Bio (TELA) | 0.4 | $1.6M | 100k | 16.11 | |
Fulcrum Therapeutics (FULC) | 0.3 | $1.5M | 146k | 10.48 | |
Intellia Therapeutics (NTLA) | 0.3 | $1.2M | 7.5k | 161.87 | |
Soc Telemed Com Cl A | 0.3 | $1.2M | 208k | 5.69 | |
Molecular Templates | 0.2 | $1.1M | 142k | 7.82 | |
Vericel (VCEL) | 0.2 | $1.1M | 20k | 52.51 | |
Forte Biosciences (FBRX) | 0.2 | $1.1M | 31k | 33.63 | |
Vera Therapeutics Cl A (VERA) | 0.2 | $1.0M | 76k | 13.26 | |
Repro-Med Systems (KRMD) | 0.2 | $932k | 201k | 4.63 | |
Atreca Cl A Com (BCEL) | 0.2 | $857k | 101k | 8.52 | |
Aslan Pharmaceuticals Ads | 0.2 | $745k | 226k | 3.30 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $648k | 50k | 12.97 | |
Aerpio Pharmaceuticals | 0.1 | $598k | 354k | 1.69 | |
Verastem | 0.1 | $512k | 126k | 4.07 | |
Ambrx Biopharma Sponsored Ads | 0.1 | $294k | 15k | 19.60 | |
Eyegate Pharmaceuticals Com New | 0.1 | $275k | 76k | 3.64 | |
Calithera Biosciences | 0.0 | $210k | 101k | 2.09 |